Козлова Т. В., Таратута Т. В., Аксенова М. Б., Хлевчук Т. В. Взаимодействие альтернативной терапии с варфарином: что необходимо знать врачам. Кардиоваскулярная терапия и профилактика. 2010;9(3):106-110.
1. Anthony M, Romero K, Malone DC, et al. Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium. Clin pharmacy Ther 2009; 86: 425—9.
2. Chagan L, Bernstein D, Cheng JW, et al. Use of biological based therapy in patients with cardiovascular diseases in a universityhospital in New York City. BMC Complement Altern Med 2005; 5: 4—13.
3. Conly JM, Stein K, Worobetz L, et al. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994; 89: 915—23.
4. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990—1997: results of a follow-up national survey. JAMA 1998; 280: 1569—75.
5. Fortun PJ, Hawkey CJ. Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 2007; 23: 134—41.
6. Foti RS, Wahlstrom JL, Wienkers LC. The in vitro drug interaction potential of dietary supplements containing multiple herbal components. Drug Metab Disp 2007; 35: 185—8.
7. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 2005; 45: 127—32.
8. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005; 165: 1095—106.
9. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs 2005; 65(9): 1239—82.
10. Joshi BS, Kaul PN. Alternative medicine: herbal drugs and their critical appraisal—part I. Prog Drug Res 2001; 56: 1—76.
11. Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994; 71: 110—1.
12. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004; 91: 119—28.
13. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. London: Pharmaceutical Press 1996.
14. Nutescu EA, Shapiro NL, Ibrahim S, et al. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 2006; 5: 433—51.
15. Stading JA, Skrabal MZ, Faulkner MA. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors. Am J Health Syst Pharm 2001; 58: 2076—80.
16. Sullivan DM, Ford MA, Boyden TW. Grapefruit juice and the response to warfarin. Am J Health Syst Pharm 1998; 55: 1581—3.
17. Takahashi H, Echizen H. Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharmacokinet 2001; 40: 587—603.
18. Thijssen HH, Soute BA, Vervoort LM, et al. Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost 2004; 92: 797—802.
19. Wittkowsky Ann K. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 2008; 25: 72—7.
20. Wood MJ, Stewart RL, Merry H, et al. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003; 145: 806—12.
21. Zhaoping LI, Seerman NP, Carpenter CL, et al. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc 2006; 106: 2057—61.
